OC5:FRA
코클리어
€58.42
arrow_downward
-6.53%(-4.08) 1D
4월 23일, 오후 10시 0분 0초 GMT+2 · EUR
search
모든 종목 코드
1D
5D
1M
6M
YTD
1Y
5Y
최대
| 종목 코드 | 가격 | 변동 | 변동률(%) |
|---|
insights_autoOC5의 주요 통계 생성 중...
시가
€58.42
고가
€58.42
저가
€58.42
시가총액
62.13억
평균 거래량
25.00
거래량
64.00
52주 최고가
€179.94
52주 최저가
€58.42
직원 수
6천
뉴스 기사
웹 소스 기반
BioWorld News
·
2시간 전
Cochlear’s 39% stock plunge resets ‘defensive growth’ narrative
Kalkine Media
·
12시간 전
What Triggered the Sharp Fall in Cochlear Shares?
프로필
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant.
Based in Sydney, Cochlear was formed in 1981 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate. As of 2022, the company holds 50% of the cochlear implant market, with more than 250,000 people receiving one of Cochlear's implants as of 2015.
Cochlear was named Australia's most innovative company by the Intellectual Property Research Institute of Australia in 2002 and 2003, and one of the world's most innovative companies by Forbes in 2011. Wikipedia
코클리어에 관한 정보